Ban-ji-ryun, ban-zhi-lian, banjiryun, Belamcanda chinensis, bergenin, betulin, betulinic acid, cis-piceid, cis-resveratrol (cis-3,4,5- trihydroxystilbene), Cissus quadrangularis, Elephantorrhiza goetzei, epsilon-Viniferin (a dimer of resveratrol), Erythrophleum lasianthum (Caesalpinioidae, Leguminosae), flavanoid, French paradox, gnetin H (a resveratrol analog), Gnetum montanum, grape seed proanthycyanidin extract (GSPE), grape skin, heyneanol A (a resveratrol tetramer), hydroxystilbene, ko-jo-kon, Liliaceae, lyophilized grape powder (LGP), mangiferonic acid, non-flavanoid polyphenol, Paeonia lactiflora Pall. (Paeoniaceae), pallidol, parthenocissine A, phenolic antioxidant, phytoalexin, phytoantitoxin, phytoestrogens, phytohormones, phytostilbene, piceatannol, Polygonum cuspidatum, polyphenol, prenylflavanone, protykin, quadrangularin, red wine, red wine polyphenol, RESV, resverol, resveratrol 3-O-beta-D-glucopyranoside, Reynoutria japonica, Scutellaria barbata D. Don (Lamiaceae), Sophora moorcroftiana Benth., Sophora tomentosa L., stilbene, stilbene derivative resveratrol (RES), stilbene polyphenol, stilbenoid, suffruticosol B (a resveratrol analog), trans-3,4',5-trihydroxystilbene, trans-piceid, trans-resveratrol, transhydroxystilbene, tyrphostin, vatdiospyroidol (a resveratrol tetramer), Vaticapauciflora, Vatica rassak (Dipterocarpaceae), vaticanol C (a resveratrol tetramer), vaticaphenol A, Veratrum taliense, viniferin (a resveratrol analog), Vitis vinifera L.
Background
Resveratrol is found in over 70 plant species including nuts, grapes, pine trees, certain vines, and red wine. Some experts believe that resveratrol may be a factor in the French paradox that coronary heart disease mortality in France is lower than other similar industrialized countries due to the frequent consumption of red wine.
Resveratrol has been shown in animal and laboratory studies to exhibit antioxidant, anticancer, antiproliferative, antifungal, antiviral, and antibacterial effects. However, data in humans is lacking.
At this time, there is a lack of high quality human trials available supporting the efficacy of resveratrol for any indication. However, there are several observational studies that correlate the consumption of wine with a decrease in cancer and/or cardiovascular disease risk. There are multiple possible contributing factors to these conditions, and studies of resveratrol are difficult to design and implement. Too much alcohol intake can be dangerous. Further research is needed before a firm recommendation can be made.
Evidence
DISCLAIMER:
These uses have been tested in humans or animals. Safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider.
Cancer:
The effects of resveratrol cannot be adequately assessed from trials using foods, wine, or combination products containing resveratrol and other substances. Well-designed clinical trials of resveratrol alone are needed before a recommendation can be made in regards to cancer prevention and/or treatment.
Grade: C
Cardiovascular disease:
The effects of resveratrol cannot be adequately assessed from trials using foods, wine, or combination products containing resveratrol and other substances. Well-designed clinical trials of resveratrol alone are needed before a recommendation can be made.
Grade: C
Tradition
WARNING:
DISCLAIMER:
The below uses are based on tradition, scientific theories, or limited research. They often have not been thoroughly tested in humans, and safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider. There may be other proposed uses that are not listed below. Helicobacter pylori
Dosing
Adults (over 18 years old)
Insufficient available evidence to recommend.
Children (under 18 years old)
Insufficient available evidence to recommend.
Safety
DISCLAIMER:
Many complementary techniques are practiced by healthcare professionals with formal training, in accordance with the standards of national organizations. However, this is not universally the case, and adverse effects are possible. Due to limited research, in some cases only limited safety information is available.
Allergies
Avoid in individuals with a known allergy/hypersensitivity to resveratrol, grapes, red wine, or red wine polyphenols.
Allergic contact dermatitis from pentylene glycol in an emollient cream, with possible co-sensitization to resveratrol has been reported.
Side Effects and Warnings
Limited data in humans reveals that resveratrol seems quite safe. It is usually found as a component in food and beverages.
There is limited long-term information regarding adverse effects associated with resveratrol supplements alone. The American Heart Association recommends limited consumption. Consumption of large quantities of red wine as a source of resveratrol is considered unsafe due to the alcohol content. Consuming large amounts of alcohol increases the risk of alcoholism, high blood pressure, obesity, stroke, breast cancer, suicide, and accidents. Drinking large quantities of red wine may also have adverse effects on the liver. Preliminary evidence suggests that resveratrol may weakly inhibit the way that the liver breaks down certain drugs, herbs, and supplements (inhibits multiple cytochrome P450 enzymes). Avoid red wine consumption in patients with a history of alcoholism.
Use cautiously in patients on anticoagulant/antiplatelet (blood thinning) agents due to the potential for increased risk of bleeding.
Patients on blood pressure medications should take high amounts of resveratrol with caution.
Use cautiously in patients taking digoxin or digoxin-like drugs. Resveratrol may interact with these agents.
Pregnancy and Breastfeeding
According to the American College of Obstetricians and Gynecologists, red wine consumption is not recommended in pregnant women, as alcohol may affect the fetus and can lead to life-threatening damage.
Interactions
Interactions with Drugs
Based on preliminary laboratory study, resveratrol may have additive effects when taken with antifungals, such as nystatin. There may be a protective effect of trans-resveratrol on gentamicin-induced kidney toxicity.
Laboratory study suggests that resveratrol has anti-aggregating and antithrombin activity and may have additive effects when taken with other drugs with the same actions. Use of resveratrol with antiplatelet drugs like clodipogrel (Plavix®), dipyridamole (Persantine®), non-steroidal anti-inflammatory drugs (NSAIDs), and aspirin or anticoagulant drugs like warfarin (Coumadin®) could cause increased risk of bleeding.
Resveratrol may increase the effects of some antivirals, including antiretroviral HIV medications.
Based on laboratory and animal study, the use of resveratrol with antihypertensive/cardiovascular drugs may result in additive effects.
Based on laboratory study, resveratrol may antagonize the effects of cardiac glycosides, such as digoxin or digoxin-like drugs.
Cholesterol levels have been lowered in rats, although the clinical significance is unknown in humans. In theory, resveratrol could increase the effects of cholesterol-lowering drugs such as HMG-CoA reductase inhibitors ("statins") or bile acid sequestering agents (cholestyramine).
Based on preliminary data, resveratrol may enhance the immune suppression caused by cyclosporine A.
Drinking large quantities of red wine, which contains resveratrol, may have adverse effects on the liver. Preliminary evidence suggests that resveratrol may weakly inhibit the way that the liver breaks down certain drugs, herbs, and supplements (inhibits multiple cytochrome P450 enzymes).
Based on resveratrol's chemical structure, which is similar to that of the synthetic estrogen agonist diethylstilbestrol, resveratrol may function as an estrogen agonist and exhibit an additive effect when taken in conjunction with estradiol. However, limited laboratory study has shown resveratrol acting as an estrogen antagonist. Resveratrol may have the potential to act as both an estrogen agonist or antagonist depending on a variety of factors.
Based on preliminary study, resveratrol may interact with MAOIs such as phenelzine (Nardil®) and tranylcypromine (Parnate®). This effect has not been confirmed in humans.
Interactions with Herbs and Dietary Supplements
Based on preliminary laboratory study, resveratrol may have additive effects when taken with antifungal herbs and supplements. There may be a protective effect of trans-resveratrol on gentamicin-induced kidney toxicity.
Laboratory study suggests that resveratrol has anti-aggregating and antithrombin activity and may have additive effects when taken with other herbs and supplements with the same actions.
Resveratrol may increase the effects of some antivirals.
Theoretically, the use of resveratrol with blood pressure-lowering or cardiovascular herbs and supplements may result in additive effects.
Resveratrol may antagonize the effects of cardiac glycoside herbs that are similar to digoxin or foxglove.
Cholesterol levels have been lowered in rats, although the clinical significance is unknown. In theory, resveratrol could increase the effects of herbs and supplements like garlic, guggul, red rice yeast, or niacin.
Drinking large quantities of red wine, which contains resveratrol, may have adverse effects on the liver. Preliminary evidence suggests that resveratrol may weakly inhibit the way that the liver breaks down certain herbs and supplements (inhibits multiple cytochrome P450 enzymes).
Based on resveratrol's chemical structure, resveratrol may function as an estrogen agonist and exhibit an additive effect when taken with estradiol. However, limited laboratory study has shown resveratrol acting as an estrogen antagonist. Resveratrol may have the potential to act as both an estrogen agonist or antagonist depending on a variety of factors.
Based on preliminary study, resveratrol may interact with MAOIs such as St. John's wort. This effect has not been confirmed in humans.
Based on laboratory study, resveratrol may increase inhibitory effects on carcinoma cells when combined with quercetin and rutin. Preliminary study also has shown that resveratrol may enhance the growth inhibitory effects of vitamin D.
Attribution
This information is based on a systematic review of scientific literature, and was peer-reviewed and edited by contributors to the Natural Standard Research Collaboration (www.naturalstandard.com): Julie Conquer, PhD (Natural Standard Research Collaboration); Dawn Costa, BA, BS (Natural Standard Research Collaboration); Nicole Giese, MS (Natural Standard Research Collaboration); Dana A. Hackman, BS (Northeastern University); Brian Szczechowski, PharmD (Massachusetts College of Pharmacy); Shaina Tanguay-Colucci, BS (Natural Standard Research Collaboration); Catherine Ulbricht, PharmD (Massachusetts General Hospital); Wendy Weissner, BA (Natural Standard Research Collaboration); Shannon Welch, PharmD (Northeastern University); Denise Wong, PharmD (Northeastern University).
Bibliography
DISCLAIMER:
Natural Standard developed the above evidence-based information based on a thorough systematic review of the available scientific articles. For comprehensive information about alternative and complementary therapies on the professional level, go to www.naturalstandard.com. Selected references are listed below.
Aggarwal BB, Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 2006 May 14;71(10):1397-421.
Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 2006 Jun;5(6):493-506.
Cheong H, Ryu SY, Kim KM. Anti-allergic action of resveratrol and related hydroxystilbenes. Planta Med 1999;65(3):266-268.
Cruz MN, Luksha L, Logman H, et al. Acute responses to phytoestrogens in small arteries from men with coronary heart disease. Am J Physiol Heart Circ Physiol 2006 May;290(5):H1969-75.
Delmas D, Lancon A, Colin D, et al. Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer. Curr Drug Targets 2006 Apr;7(4):423-42.
Gronbaek M, Deis A, Sorensen TI, et al. Mortality associated with moderate intakes of wine, beer, or spirits. BMJ 5-6-1995;310(6988):1165-1169.
Labinskyy N, Csiszar A, Veress G, et al. Vascular dysfunction in aging: potential effects of resveratrol, an anti-inflammatory phytoestrogen. Curr Med Chem 2006;13(9):989-96.
Lekakis J, Rallidis LS, Andreadou I, et al. Polyphenolic compounds from red grapes acutely improve endothelial function in patients with coronary heart disease. Eur J Cardiovasc Prev Rehabil 2005 Dec;12(6):596-600.
Levi F, Pasche C, Lucchini F, et al. Resveratrol and breast cancer risk. Eur.J Cancer Prev 2005;14(2):139-142.
Rahman I, Kilty I. Antioxidant therapeutic targets in COPD. Curr Drug Targets 2006 Jun;7(6):707-20.
Rakici O, Kiziltepe U, Coskun B, et al. Effects of resveratrol on vascular tone and endothelial function of human saphenous vein and internal mammary artery. Int J Cardiol 2005 Nov 2;105(2):209-15.
Truelsen T, Gronbaek M, Schnohr P, et al. Intake of beer, wine, and spirits and risk of stroke: the Copenhagen city heart study. Stroke 1998;29(12):2467-2472.
Zern TL, Wood RJ, Greene C, et al Grape polyphenols exert a cardioprotective effect in pre- and postmenopausal women by lowering plasma lipids and reducing oxidative stress. J Nutr 2005;135(8):1911-1917.
Remember, keep this and all other medicines out of the reach of children,
never share your medicines with others, and use this medication only for the indication prescribed.
